Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Large Cap | Pharmaceuticals & Drugs
1175.55
-10.90 (-0.92%)
< Home < Back

Dr. Reddy's Lab - Quaterly Results

Date: 09-05-2025
The company witnessed a 8.97% growth in the revenue at Rs. 55629.00 millions for the quarter ended March 2025 as compared to Rs. 51048.00 millions during the year-ago period.Net profit stood at Rs. 12007.00  millions  compared to Rs. 10348.00 millions in the corresponding previous quarter,high by 16.03%.Operating profit for the quarter ended March 2025 rose to 18574.00 millions as compared to 15913.00 millions of corresponding quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 55629.00 51048.00 8.97 231154.00 194838.00 18.64 231154.00 194838.00 18.64
Other Income 4144.00 2127.00 94.83 10034.00 8623.00 16.36 10034.00 8623.00 16.36
PBIDT 18574.00 15913.00 16.72 83852.00 67887.00 23.52 83852.00 67887.00 23.52
Interest 311.00 59.00 427.12 1099.00 218.00 404.13 1099.00 218.00 404.13
PBDT 18263.00 15854.00 15.19 82753.00 67669.00 22.29 82753.00 67669.00 22.29
Depreciation 2645.00 2462.00 7.43 10394.00 9756.00 6.54 10394.00 9756.00 6.54
PBT 15618.00 13392.00 16.62 72359.00 57913.00 24.94 72359.00 57913.00 24.94
TAX 3611.00 3044.00 18.63 18865.00 14493.00 30.17 18865.00 14493.00 30.17
Deferred Tax -32.00 342.00 -109.36 960.00 875.00 9.71 960.00 875.00 9.71
PAT 12007.00 10348.00 16.03 53494.00 43420.00 23.20 53494.00 43420.00 23.20
Equity 834.00 834.00 0.00 834.00 834.00 0.00 834.00 834.00 0.00
PBIDTM(%) 33.39 31.17 7.11 36.28 34.84 4.11 36.28 34.84 4.11